Cargando…
Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
BACKGROUND: Methylated arginines are endogenous analogues of L-arginine, the substrate for nitric oxide (NO) synthase. Asymmetric dimethylarginine (ADMA) interferes with NO formation, causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in humans. It is elimina...
Autores principales: | Leypoldt, Frank, Choe, Chi-Un, Gelderblom, Mathias, von Leitner, Eike-Christin, Atzler, Dorothee, Schwedhelm, Edzard, Gerloff, Christian, Sydow, Karsten, Böger, Rainer H., Magnus, Tim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753663/ https://www.ncbi.nlm.nih.gov/pubmed/19809508 http://dx.doi.org/10.1371/journal.pone.0007337 |
Ejemplares similares
-
Dimethylarginine Dimethylaminohydrolase1 Is an Organ-Specific Mediator of End Organ Damage in a Murine Model of Hypertension
por: Sydow, Karsten, et al.
Publicado: (2012) -
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023) -
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study
por: Yola, Ibrahim Musa, et al.
Publicado: (2021) -
Incidence of All-Cause and Cardiovascular Mortality Predicted by Symmetric Dimethylarginine in the Population-Based Study of Health in Pomerania
por: Schwedhelm, Edzard, et al.
Publicado: (2014) -
Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction
por: Kleist, Christine J., et al.
Publicado: (2022)